Fitch affirms Allergan

Fitch Ratings said it has affirmed the following ratings of Allergan, Inc.: issuer default rating at A- ; senior unsecured debt rating at' A-; bank loan rating at A-; short-term issuer default rating at F2; and commercial paper rating at F2.

The ratings apply to about $1.64 billion of outstanding debt, the agency said, noting that the outlook is revised to stable from positive.

Allergan sustained above-market revenue growth at 11.8% during 2008 despite 30% of the company's business depending on demand from cash-paying customers, Fitch said.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.